×
About 1,035 results

ALLMedicine™ Antithrombin LII Center

Research & Reviews  350 results

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
https://clinicaltrials.gov/ct2/show/NCT04651400

Aug 2nd, 2022 - Multicentre, multinational, non-interventional, observational, retrospective, patient record study to evaluate changes in coagulation parameters in patients with severe COVID-19 infection receiving/not treatment with antithrombin (AT) III

Antithrombin Deficiency
https://emedicine.medscape.com/article/198573-print

Jul 29th, 2022 - Practice Essentials Antithrombin (AT; also called heparin cofactor I; previously referred to as antithrombin III) is a 58-kDa molecule belonging to the serine protease inhibitor (serpin) superfamily that plays a central role in anticoagulation and...

Antithrombin Deficiency
https://emedicine.medscape.com/article/198573-overview

Jul 29th, 2022 - Practice Essentials Antithrombin (AT; also called heparin cofactor I; previously referred to as antithrombin III) is a 58-kDa molecule belonging to the serine protease inhibitor (serpin) superfamily that plays a central role in anticoagulation and...

Antithrombin Deficiency
http://emedicine.medscape.com/article/198573-overview

Jul 29th, 2022 - Practice Essentials Antithrombin (AT; also called heparin cofactor I; previously referred to as antithrombin III) is a 58-kDa molecule belonging to the serine protease inhibitor (serpin) superfamily that plays a central role in anticoagulation and...

Echocardiographic phenotypes of Chinese patients with type 2 diabetes may indicate earl...
https://doi.org/10.1002/ehf2.14062
ESC Heart Failure; Wang Z, Wang C et. al.

Jul 14th, 2022 - Type 2 diabetes may impair cardiac structure and function at very early stage, other factors, for example, obesity and hypertension, can induce aforementioned abnormalities individually. This study aimed to explore precise prevention and treatment...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  47 results

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
https://clinicaltrials.gov/ct2/show/NCT04651400

Aug 2nd, 2022 - Multicentre, multinational, non-interventional, observational, retrospective, patient record study to evaluate changes in coagulation parameters in patients with severe COVID-19 infection receiving/not treatment with antithrombin (AT) III

Antithrombin III Concentrate After Liver Transplantation
https://clinicaltrials.gov/ct2/show/NCT04219579

Jul 1st, 2022 - Antithrombin III(AT-III) concentrates have been used to prevent critical thrombosis in the immediate post-liver transplantation period without clear evidence regarding the optimal dose or administration scheme. The investigators retrospectively an...

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO
https://clinicaltrials.gov/ct2/show/NCT04879550

May 24th, 2022 - ECMO is applied in patients with acute severe heart or lung failure. The treatment protocol of patients undergoing ECMO is carefully arranged against the risk of bleeding / thrombosis. According to the general protocol, heparin infusion therapy is...

Antithrombin III in Infectious Disease Caused by COVID-19
https://clinicaltrials.gov/ct2/show/NCT04899232

Apr 12th, 2022 - The purpose of this research study is to see if participants who have SARS-CoV-2 and low levels of AT3 in the blood will benefit by being given AT3.

Application of ROTEM Technology in Aortic Surgery
https://clinicaltrials.gov/ct2/show/NCT05171023

Dec 28th, 2021 - The patient is monitored in the intensive care unit according to the following scheme: ROTEM (NATEM, INTEM, EXTEM, FIBTEM; with high clotting time (CT) values in INTEM - HEPTEM is done) and a coagulogram (activated coagulation time (ACT), activate...

see more →

News  14 results

Fast Five Quiz: Direct Oral Anticoagulant Therapy for Atrial Fibrillation
https://reference.medscape.com/viewarticle/924960_2

Apr 2nd, 2020 - Figure 1. The physiological cascade of blood clotting. Three of the four DOAC agents approved as anticoagulation therapy for patients with AF work through direct FXa inhibition (rivaroxaban, apixaban, edoxaban) or direct thrombin inhibition (dabig...

Heparin-Induced Bullous Hemorrhagic Dermatosis Confined to the Oral Mucosa
https://www.mdedge.com/dermatology/article/202369/contact-dermatitis/heparin-induced-bullous-hemorrhagic-dermatosis
Hannah B. Harris, MD, Benjamin J. Kurth, MD et. al.

Jun 5th, 2019 - Heparin is a naturally occurring anticoagulant and is commonly used to treat or prevent venous thrombosis or the extension of thrombosis. 1 Heparin is composed of 15-kDa chains of complex polysaccharides with repeating pentasaccharide sequences.

Fast Five Quiz: Test Your Knowledge of Venous Thromboembolism
https://reference.medscape.com/viewarticle/902400_2

Dec 3rd, 2018 - Nephrotic syndrome is one of several disease states that increase a patient's risk of developing VTE. VTE associated with nephrotic syndrome appears to be due to a hypercoagulable state resulting from urinary loss of anticoagulant proteins, togeth...

More Lab Tests Deemed Inappropriate
https://www.staging.medscape.com/viewarticle/887645

Oct 26th, 2017 -                           The American Society of Clinical Pathology (ASCP) has added five tests to the list it considers unnecessary or potentially harmful, as part of the Choosing Wisely campaign. The list has now grown to 20 recommendations. Th...

More Lab Tests Deemed Inappropriate
https://www.medscape.com/viewarticle/887645

Oct 26th, 2017 -                           The American Society of Clinical Pathology (ASCP) has added five tests to the list it considers unnecessary or potentially harmful, as part of the Choosing Wisely campaign. The list has now grown to 20 recommendations. Th...

see more →